Instil Bio, Inc. — Form D
Instil Bio, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-23. The offering totals $185.4M, of which $185.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-02-23
- Form: D
- Accession: 0001789769-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $185.4M
- Amount sold: $185.4M
- Investors: 26
- Date of first sale: 2020-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-390158
Issuer
- Name: Instil Bio, Inc.
- CIK: 0001789769
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 3963 Maple Avenue, Suite 350, DALLAS, TX, 75219
- Phone: 240-676-3715
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Gwen Binder | Director | Dallas, TX |
| Bronson Crouch | Director | Dallas, TX |
| Neil Gibson | Director | Glasgow, X0 |
| George Matcham | Director | Dallas, TX |
| Kent McGaughy | Director | Dallas, TX |
| Jack Nielsen | Director | Palo Alto, CA |
| Nimish Shah | Director | Dallas, TX |
| Bronson Crouch | Executive Officer | Dallas, TX |
| Sandeep Laumas | Executive Officer | Greenwich, CT |
| Margo Roberts | Director | South San Francisco, CA |
| Robert Hawkins | Director | Dallas, TX |
| Mariam Morris | Executive Officer | Dallas, TX |
Other filings by this issuer (4)
More